Anatara Lifesciences Ltd (AU:ANR)
ASX:ANR
Total Valuation
Anatara Lifesciences Ltd has a market cap or net worth of AU$3.16M. The enterprise value is AU$786.10K.
Market CapAU$3.16M
Enterprise ValueAU$786.10K
Share Statistics
Anatara Lifesciences Ltd has 315,950,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding315,950,780
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Anatara Lifesciences Ltd’s return on equity (ROE) is -3.65 and return on invested capital (ROIC) is -103.96%.
Return on Equity (ROE)-3.65
Return on Assets (ROA)-1.70
Return on Invested Capital (ROIC)-103.96%
Return on Capital Employed (ROCE)-3.62
Revenue Per Employee138.49K
Profits Per Employee-279.24K
Employee Count7
Asset Turnover0.84
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Anatara Lifesciences Ltd is ―. Anatara Lifesciences Ltd’s PEG ratio is 0.25.
PE Ratio―
PS Ratio1.06
PB Ratio1.91
Price to Fair Value1.91
Price to FCF-0.45
Price to Operating Cash Flow-5.37
PEG Ratio0.25
Income Statement
In the last 12 months, Anatara Lifesciences Ltd had revenue of 969.46K and earned -1.95M in profits. Earnings per share was -0.01.
Revenue969.46K
Gross Profit-633.97K
Operating Income-1.96M
Pretax Income-1.95M
Net Income-1.95M
EBITDA-1.96M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -404.19K and capital expenditures -1.00, giving a free cash flow of -404.20K billion.
Operating Cash Flow-404.19K
Free Cash Flow-404.20K
Free Cash Flow per Share>-0.01
Dividends & Yields
Anatara Lifesciences Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change-9.09%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)25.84
Average Volume (3m)759.89K
Important Dates
Anatara Lifesciences Ltd upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateMar 3, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
Anatara Lifesciences Ltd as a current ratio of 1.89, with Debt / Equity ratio of 0.00%
Current Ratio1.89
Quick Ratio1.89
Debt to Market Cap0.40
Net Debt to EBITDA-0.16
Interest Coverage Ratio-263.70
Taxes
In the past 12 months, Anatara Lifesciences Ltd has paid -969.46K in taxes.
Income Tax-969.46K
Effective Tax Rate0.50
Enterprise Valuation
Anatara Lifesciences Ltd EV to EBITDA ratio is -0.68, with an EV/FCF ratio of -0.59.
EV to Sales1.37
EV to EBITDA-0.68
EV to Free Cash Flow-0.59
EV to Operating Cash Flow-0.59
Balance Sheet
Anatara Lifesciences Ltd has AU$1.09M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$1.09M billion.
Cash & Marketable SecuritiesAU$1.09M
Total DebtAU$0.00
Net CashAU$1.09M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is -54.80%, with operating margin of -201.83%, and net profit margin of -201.63%.
Gross Margin-54.80%
Operating Margin-201.83%
Pretax Margin-201.63%
Net Profit Margin-201.63%
EBITDA Margin-201.76%
EBIT Margin-201.83%
Analyst Forecast
The average price target for Anatara Lifesciences Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast1.03%